Key Points Analysts at H.C. Wainwright doubled their price target on Plug Power stock last week. Plug shares gained 60% by the end of the week. Plug stock is up again today, but still unprofitable. 10 stocks we like better than Plug Power › Plug Power (NASDAQ: PLUG) stock soared to close at $3.81 per share Friday, a 60% gain for the week. The hydrogen fuel stock actually only had one "down" day all week long, and its ascent looks set to continue today, with the stock up 4.5% through 10:35 a.m. ET. ...

Core Viewpoint - FuelCell Energy's stock surged 22% following an analyst upgrade of a rival company, Plug Power, despite no direct mention of FuelCell in the upgrade [1][2]. Group 1: Analyst Insights - H.C. Wainwright raised Plug Power's price target from $3 to $7 per share, citing increased demand for electricity produced by fuel cells due to rising electricity prices [2][4]. - The analyst noted a preference for nuclear power stocks over hydrogen stocks, which raises questions about the sustainability of the price increase for both Plug and FuelCell [4][7]. Group 2: Market Dynamics - Plug Power has a short interest of 31%, making it susceptible to a short squeeze, which could explain the stock price increase [5]. - In contrast, FuelCell has a lower short interest of only 7%, suggesting less market speculation driving its stock price [5]. Group 3: Financial Performance - FuelCell Energy remains unprofitable, with no expectations for profitability before 2030, leading to skepticism about its stock performance [6][7]. - Analysts from The Motley Fool Stock Advisor have identified ten stocks they believe are better investment opportunities than FuelCell Energy [8].

LIQUIDATION ALERT 🚨$6,060,000,000 IN SHORTS WILL GET LIQUIDATED IF $ETH HITS $5,000.SHORT SQUEEZE IS COMING. https://t.co/jvIWP3juAE ...

BNB Hits All-Time High as Network Upgrades and Short Squeeze Fuel Rally► https://t.co/ZOgYFkeWkQ https://t.co/ZOgYFkeWkQ ...

Welcome back to the Crypto Watch channel everyone. My name is Josh and right now Bitcoin is still massively playing out the short-term bullish divergence as my Bitcoin long position is continuing to explode further into profits. So, in just a moment, I'll be talking about exactly how I plan to make a lot of quick and easy profits from the next Bitcoin move about to happen very soon.While the price of Bitcoin is now running into a very crucial level on the price chart that we need to pay attention to, while ...

$ETH SHORT SQUEEZE INCOMING. https://t.co/kLuOZhOakN ...

LIQUIDATION ALERT 🚨$10,000,000,000 IN SHORTS WILL GET LIQUIDATED IF $ETH PUMPS 10%.SHORT SQUEEZE COMING? https://t.co/YufbuWfEE9 ...

$ETH DOWNSIDE LIQUIDITY HAS BEEN TAKEN OUT COMPLETELY.IT SEEMS LIKE A SHORT-SQUEEZE IS COMING 🚀 https://t.co/wBdDaxcRwm ...

Core Viewpoint - Retail investors are actively seeking potential short squeeze opportunities, with JPMorgan identifying three stocks that are gaining traction among retail investors while facing increased short interest from institutional investors [1][2]. Group 1: Retail Investor Activity - Retail investors have shown significant buying interest in Cipher, purchasing $14.2 million worth of its stock recently [3]. - TeraWulf has the highest short interest, with 40% of its total float being shorted, while Nuvation has 28% and Cipher has 20% [3]. - Positive social media sentiment has consistently favored Cipher over the past month, while TeraWulf's sentiment has been more volatile and has recently declined [5]. Group 2: Short Seller Interest - Short interest in TeraWulf has increased by 8% in the last month, indicating growing bearish sentiment among short sellers [4]. - Although short interest in Cipher has declined recently, it still remains elevated at approximately 20% of its float [3][4]. Group 3: Market Reactions - Cipher's stock experienced a 10% increase in premarket trading following news of Google taking a stake in the company, but ultimately fell 15% by the end of the trading day [4]. - TeraWulf's stock also surged previously due to a similar deal, highlighting the impact of strategic partnerships on stock performance [4].

It’s a sign that’s impossible to ignore. As you soon as you pull up the Price Overview for Recursion Pharmaceuticals (RXRX), you’re greeted with a clear message: Barchart’s Technical Opinion indicator rates RXRX stock as a 72% Strong Sell. From an empirical perspective, suggesting a contrarian position would place you on shaky ground. Since the start of the year, RXRX stock is down nearly 28%, which in many respects is understandable given the uncertainties associated with the broader healthcare ecosystem ...